INTERNATIONAL PATENT: ROSWELL PARK CANCER INSTITUTE CORPORATION FILES APPLICATION FOR "COMPLEMENT SIGNALING AS A T-CELL CHECKPOINT IN THE TUMOR MICROENVIRONMENT (TME)"

GENEVA, Oct. 15 -- ROSWELL PARK CANCER INSTITUTE CORPORATION (Elm And Carlton StreetsBuffalo, NY 14263) filed a patent application (PCT/US2025/023444) for "COMPLEMENT SIGNALING AS A T-CELL CHECKPOINT IN THE TUMOR MICROENVIRONMENT (TME)" on Apr 07, 2025. With publication no. WO/2025/213167, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SEGAL, Brahm (66 Forestglen CircleWilliamsville, NY 14221), GIRIDHARAN, Thejaswini (675 Delaware Avenue, Apt. 806Buffalo, NY 14209), MCGRAY, Robert (Elm And Carlton StreetsBuffalo, NY 1426...